Join Novo Nordisk and make a difference in the lives of millions of patients living with Sickle Cell Disease (SCD).
We are seeking an experienced professional to lead strategic commercial opportunity mapping, deepen SCD market understanding, and drive business development projects for Saudi. This exciting opportunity is for the role of Sr Business Development Manager, Sickle Cell Disease (SCD) based in Riyadh, Saudi, reporting to the Director of Rare Diseases Business Unit.
Apply today and embark on a life-changing career with us!
Your new role
You will be pivotal in cultivating strong internal and external relationships to advance patient care and positioning Novo Nordisk as a pioneer in the SCD therapy area through a comprehensive understanding of clinical care pathways, treatment landscapes, and strategic collaborations, in accordance with business ethics and compliance.
Your key responsibilities will be to:
Your skills & qualifications
You need to have:
Your new department
Rare Disease business unit in Saudi consists of highly motivated, energetic, and focused team who is passionate about providing a better quality of life to patients. Rare Disease Portfolio is divided into the Rare Endocrine Disorders and the Rare Blood Disorders. We aspire to launch innovative medications for patients who live with SCD in the future. At Novo Nordisk Saudi, we use our skills, dedication, and ambition to drive change in rare diseases. By working with us, you will have the opportunity to fight against rare diseases - together, we can make a difference!
Working at Novo Nordisk
Novo Nordisk is its people. We know that life is anything but linear, and balancing what is important at different stages of our career is never easy. That’s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 64,000 employees. Together, we go further. Together, we’re life changing
What we offer
Beyond a competitive compensation package, we offer continuous learning, global mobility opportunities, and a people-first culture. Our benefits are thoughtfully designed to support both your professional ambitions and personal well-being—at every stage of your journey.
Deadline
6th February 202 6
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and preventing diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html